WASHINGTON, July 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced leadership additions to its clinical and financial teams, as it continues to drive innovation in specialty care.
Physician, executive and startup entrepreneur Dr. David Lim has joined the company as chief clinical officer, where he will lead Evolent's 300-person medical team to support daily operations and innovation. Dr. Lim brings deep experience in value-based care, technology-enabled healthcare and patient engagement. Before joining Evolent, he served as chief medical officer (CMO) of RightMove Health, a virtual physical therapy company he helped to grow from the ground up as its first employee. Dr. Lim has also served as chief technology innovation officer for value-based care company InnovaCare Health, founding team member and CMO of behavioral health company Quartet Health, and director of clinical design for Castlight Health, which provided healthcare services cost and quality data to members of self-insured employers.
Additionally, John Way has joined Evolent as CFO, Performance Suite, where he will oversee all financial aspects of the company's at-risk specialty condition management products. Mr. Way brings more than 20 years of executive financial management experience to the role, including as CFO of OptumHealth and OptumCare. He combines deep subject matter expertise in risk-based value arrangements with an innovator's perspective to drive success for Evolent and its partners.
"I'm excited to welcome Dave and John, not just because of their deep experience but also their commitment to transforming specialty care for patients, payers and providers," said Evolent CEO and Co-Founder Seth Blackley. "As these additions show, Evolent remains a leading destination for talented and accomplished leaders in our field."
Dr. Lim will report to Chief Medical Officer Dr. Von Nguyen, while Mr. Way will report to CFO John Johnson.
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.
Media inquiries
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$4.22 |
| Daily Change: | 0.02 0.48 |
| Daily Volume: | 1,018,614 |
| Market Cap: | US$470.950M |
November 06, 2025 November 06, 2025 September 23, 2025 August 07, 2025 | |

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load